Biomedical Engineering Reference
In-Depth Information
Labarre, D., Vauthier, C., Chauvierre, C., Petri, B., Muller, R.H., and Chehimi, M.M. 2005. Interactions of
blood proteins with poly (isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush.
Biomaterials . 26:5075-84.
Lehner, R., Wang, X., Marsch, S., and Hunziker, P. 2013. Intelligent nanomaterials for medicine: Carrier plat-
forms and targeting strategies in the context of clinical application. Nanomedicine:NBM 9:742-757.
Lemarchand, C., Gref, R., and Couvreur, P. 2004. Polysaccharide-decorated nanoparticles. Eur. J. Pharm.
Biopharm. 58:327-41.
Li, S.D. and Huang, L. 2008. Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm . 5:496-504.
Lira, M.C.B., Santos-Magalhães, N.S., Nicolas, V., Marsaud, V., Silva, M.P., Ponchel, G. et al. 2011. Cytotoxicity
and cellular uptake of newly synthesized fucoidan-coated nanoparticles. Eur. J. Pharm. Biopharm .
79:162-70.
Liu, F., Laurent, S., Fattahi, H., Vander Elst, L., and Muller, R.N. 2011. Superparamagnetic nanosystems based
on iron oxide nanoparticles for biomedical imaging. Nanomedicine (Lond) . 6:519-28.
Lynch, I., Cedervall, T., Lundqvist, M., Cabaleiro-Lago, C., Linse, S. et  al. 2007. The nanoparticle-protein
complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv.
Colloid Interface Sci. 134-135:167-74.
Moyano, D.F. and Rotello, V.M. 2011. Nano meets biology: Structure and function at the nanoparticle inter-
face. Langmuir . 27:10376-85.
Mura, S. and Couvreur, P. 2012. Nanotheranostics for personalized medicine. Adv. Drug Deliv. Rev .
64:1394-416.
Nicolas, J. and Couvreur, P. 2009. Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines. Wiley
Interdiscip. Rev. Nanomed. Nanobiotechnol . 1:111-27.
Nicolas, J. and Vauthier, C. 2011. Poly(alkylcyanoacrylate) nanosystems. In Intracellular Delivery Fundamental
Biomedical Technologies ed. A. Prokov, pp. 225-251. New York: Springer, Volume 5, Part 2.
Nilsson, B., Ekdahl, K.N., Mollnes, T.E., and Lambris, J.D. 2007. The role of complement in biomaterial-
induced inflammation. Mol. Immunol. 44:82-94.
Norde, W. 2008. My voyage of discovery to proteins in flatland…and beyond. Coll. Surf. B. Biointerface .
61:1-9.
Owens, D.E. and Peppas, N.A. 2006. Opsonization, biodistribution and pharmacokinetics of polymeric
nanoparticles. Int. J. Pharm. 307:93-102.
Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K. et al. 1991. Sterically
stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl.
Acad. Sci. U.S.A . 88:11460-4.
Passirani, C., Ferrarini, L,. Barratt, G., Devissaguet, J.P., and Labarre, D. 1999. Preparation and character-
ization of nanoparticles bearing heparin or dextran covalently-linked to poly(methyl methacrylate ).
J. Biomater. Sci. Polym. Ed . 10:47-62.
Peracchia, M.T., Fattal, E., Desmaële, D., Besnard, M., Noël, J.P., Gomis, J.M. et al. 1999. Stealth PEGylated
polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J. Control. Release.
60:121-8.
Szebeni, J., Muggia, F., Gabizon, A., and Barenholz, Y. 2011. Activation of complement by therapeutic lipo-
somes and other lipid excipient-based therapeutic products: Prediction and prevention. Adv. Drug Deliv.
Rev. 63:1020-30.
Vauthier, C., Labarre, D., and Ponchel, G. 2007. Design aspects on poly(alkylcyanoacrylate) nanoparticles for
targeted drug delivery. J. Drug Targeting. 15:641-63.
Vauthier, C., Lindner, P., and Cabane, B., 2009. Configuration of bovine serum albumin adsorbed on polymer
particles with grafted dextran corona. Coll. Surf. B: Biointerfaces . 69:207-15.
Vauthier, C., Persson, B., Lindner, P., and Cabane, B. 2011. Protein adsorption and complement activation for
di-block copolymer nanoparticles. Biomaterials . 32:1646-56.
Vonarbourg, A., Passirani, C., Saulnier, P., and Benoit, J.P. 2006. Parameters influencing the stealthiness of col-
loidal drug delivery systems. Biomaterials . 27:4356-73.
Walczyk, D., Baldelli Bombelli, F., Monopoli, M.P., Lynch, I., and Dawson, K.A. 2010. What the cell sees in
bionanoscience. J. Am. Chem. Soc. 132:5761-68.
Walkey, C.D. and Chan, W.C.W. 2012. Understanding and controlling the interaction of nanomaterials with
proteins in a physiological environment. Chem. Soc. Chem. 41, 2780-99.
Walkey, C.D., Olsen, J.B., Guo, H., Emili, A., and Chan, W.C. 2012. Nanoparticle size and surface chemistry
determine serum protein adsorption and macrophage uptake . J. Am. Chem. Soc. 134:2139-47.
Wang, R., Billone, P.S., and Mullet, W.M. 2013. Nanomedicine in action: An overview of cancer nanomedicine
on the market and in clinical trials. J. Nanomed. DOI:10.1155/2013/629681, Article ID: 629681, 12 pages.
Search WWH ::




Custom Search